Sofinnova Investments as of March 31, 2020
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 64 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 12.6 | $136M | 1.9M | 72.00 | |
| Ascendis Pharma A S (ASND) | 11.6 | $125M | 1.1M | 112.61 | |
| Nextcure (NXTC) | 9.2 | $99M | 2.7M | 37.07 | |
| Natera (NTRA) | 8.6 | $93M | 3.1M | 29.86 | |
| Principia Biopharma | 7.8 | $84M | 1.4M | 59.38 | |
| Y Mabs Therapeutics | 5.3 | $57M | 2.2M | 26.10 | |
| Merck & Co (MRK) | 3.3 | $36M | 464k | 76.94 | |
| Coherus Biosciences (CHRS) | 2.9 | $31M | 1.9M | 16.22 | |
| Galera Therapeutics (GRTX) | 2.7 | $29M | 3.1M | 9.50 | |
| Alexion Pharmaceuticals | 2.6 | $28M | 307k | 89.79 | |
| Merus N V (MRUS) | 2.2 | $24M | 2.0M | 12.10 | |
| United Therapeutics Corporation (UTHR) | 2.0 | $22M | 234k | 94.82 | |
| Amarin Corporation | 1.9 | $21M | 5.2M | 4.00 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.9 | $20M | 86k | 237.96 | |
| BioMarin Pharmaceutical (BMRN) | 1.9 | $20M | 240k | 84.50 | |
| Biogen Idec (BIIB) | 1.5 | $17M | 53k | 316.36 | |
| Acceleron Pharma | 1.4 | $15M | 165k | 89.87 | |
| Kiniksa Pharmaceuticals | 1.3 | $14M | 923k | 15.48 | |
| Nucana Biomed ordinary shares | 1.3 | $14M | 2.4M | 5.83 | |
| Nucana Plc american depositary shares | 1.2 | $13M | 2.3M | 5.83 | |
| Ptc Therapeutics I (PTCT) | 1.2 | $13M | 292k | 44.61 | |
| Obseva Sa | 1.1 | $11M | 4.7M | 2.41 | |
| Sarepta Therapeutics (SRPT) | 0.9 | $9.9M | 102k | 97.81 | |
| Kala Pharmaceuticals | 0.9 | $9.8M | 1.1M | 8.79 | |
| Myokardia | 0.8 | $8.2M | 175k | 46.87 | |
| Align Technology (ALGN) | 0.7 | $8.1M | 47k | 173.95 | |
| Gilead Sciences Inc option | 0.7 | $7.5M | 100k | 74.75 | |
| Kala Pharmaceuticals Inc put | 0.6 | $6.5M | 737k | 8.79 | |
| Kadmon Hldgs | 0.6 | $6.4M | 1.5M | 4.19 | |
| Chiasma | 0.6 | $5.9M | 1.6M | 3.65 | |
| Mirum Pharmaceuticals (MIRM) | 0.5 | $5.9M | 419k | 14.00 | |
| Heron Therapeutics (HRTX) | 0.5 | $5.7M | 482k | 11.74 | |
| Puma Biotechnology (PBYI) | 0.5 | $5.4M | 638k | 8.44 | |
| Amicus Therapeutics (FOLD) | 0.4 | $4.9M | 526k | 9.24 | |
| Iterum Therapeutics | 0.4 | $4.7M | 1.7M | 2.71 | |
| Iovance Biotherapeutics Inc call | 0.4 | $4.5M | 150k | 29.94 | |
| Axsome Therapeutics (AXSM) | 0.4 | $4.3M | 73k | 58.82 | |
| Abbvie (ABBV) | 0.4 | $3.8M | 50k | 76.22 | |
| Blueprint Medicines (BPMC) | 0.3 | $3.7M | 63k | 58.46 | |
| Calithera Biosciences | 0.3 | $3.6M | 819k | 4.44 | |
| Homology Medicines | 0.3 | $3.6M | 231k | 15.54 | |
| Applied Genetic Technol Corp C | 0.3 | $3.5M | 1.1M | 3.28 | |
| Akero Therapeutics Inc put | 0.3 | $3.2M | 150k | 21.19 | |
| Akero Therapeutics (AKRO) | 0.3 | $3.1M | 148k | 21.20 | |
| Entasis Therapeutics Holdings Ord | 0.3 | $3.1M | 1.2M | 2.64 | |
| Otonomy | 0.3 | $3.0M | 1.5M | 1.97 | |
| ALNYLAM PHARMACEUTICALS INC. Common Stock cmn | 0.3 | $2.9M | 27k | 108.83 | |
| Tg Therapeutics (TGTX) | 0.3 | $2.7M | 275k | 9.84 | |
| Chemocentryx | 0.2 | $2.7M | 67k | 40.18 | |
| Rigel Pharmaceuticals | 0.2 | $2.3M | 1.4M | 1.56 | |
| Ptc Therapeutics | 0.2 | $2.2M | 50k | 44.60 | |
| Compugen (CGEN) | 0.2 | $2.2M | 300k | 7.26 | |
| Sage Therapeutics (SAGE) | 0.2 | $2.1M | 74k | 28.73 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $2.0M | 1.9M | 1.04 | |
| Zymeworks | 0.2 | $1.8M | 50k | 35.49 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $1.6M | 816k | 2.00 | |
| Menlo Therapeutics | 0.1 | $1.6M | 605k | 2.68 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $1.3M | 50k | 26.79 | |
| Mersana Therapeutics | 0.1 | $1.3M | 225k | 5.83 | |
| Synlogic | 0.1 | $989k | 575k | 1.72 | |
| Zogenix | 0.1 | $816k | 33k | 24.74 | |
| Fate Therapeutics (FATE) | 0.1 | $811k | 37k | 22.19 | |
| Intra Cellular Therapies (ITCI) | 0.1 | $799k | 52k | 15.36 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $104k | 143k | 0.73 |
